Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
GAITHERSBURG, Md., April 23, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer
GlobeNewswireApr 23 16:15 ET
Shuttle Pharmaceuticals Files to Sell Subscription Rights to Buy $4.5M in Units
Seeking AlphaApr 5 17:27 ET
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
Globe NewswireApr 3 09:00 ET
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
Yahoo FinanceApr 3 07:00 ET
12 Health Care Stocks Moving In Friday's After-Market Session
GainersSalarius Pharmaceuticals (NASDAQ:SLRX) shares rose 33.9% to $0.83 during Friday's after-market session. The market value of their outstanding shares is at $3.2 million. Masimo (NASDAQ:MASI) sha
BenzingaMar 22 17:33 ET
Express News | Shuttle Pharmaceuticals Q4 EPS $(0.11) Down From $(0.06) YoY
Moomoo 24/7Mar 22 09:00 ET
Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma"), a discovery and development stage specialty pharmaceutical company focused...
PR NewswireMar 22 09:00 ET
Express News | Shuttle Pharmaceuticals Has Been Granted European Patent Number EP3737376 Titled "Selective Histone Deacetylase Inhibitors For The Treatment Of Human Diseases (Including Cancers, Neurological Disorders, And Immunological Disorders)"
Moomoo 24/7Mar 18 11:02 ET
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on March 6, 2024
Webcast presentation to take place at 11:25am ETROCKVILLE, Md., March 05, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty
GlobeNewswireMar 5 09:00 ET
Presenting on the Emerging Growth Conference 68 Day 1 on March 6 Register Now
Yahoo FinanceMar 5 07:00 ET
Shuttle Pharmaceuticals to Launch $4.5 Million Rights Offering
InvestingFeb 13 08:42 ET
Shuttle Pharmaceuticals Advances Prostate Cancer Diagnostics Funding
TipRanksFeb 13 08:13 ET
Shuttle Pharmaceuticals Bolsters Investor Relations With New Partnership
TipRanksFeb 6 04:55 ET
Shuttle Pharmaceuticals Acquires Promising Prostate Cancer Technology
TipRanksFeb 6 04:55 ET
Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the...
PR NewswireJan 23 16:30 ET
12 Health Care Stocks Moving In Monday's Intraday Session
GainersSagimet Biosciences (NASDAQ:SGMT) stock rose 103.5% to $13.88 during Monday's regular session. The company's market cap stands at $317.8 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved up
BenzingaJan 22 12:31 ET
12 Health Care Stocks Moving In Friday's Intraday Session
GainersEdgewise Therapeutics (NASDAQ:EWTX) stock moved upwards by 35.8% to $13.15 during Friday's regular session. The market value of their outstanding shares is at $834.8 million. Bullfrog AI Hldgs
BenzingaJan 19 12:31 ET
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersAssure Hldgs (NASDAQ:IONM) stock moved upwards by 13.3% to $0.31 during Thursday's after-market session. The company's market cap stands at $2.0 million. Shuttle Pharmaceuticals (NASDAQ:SHPH) s
BenzingaJan 18 16:31 ET
Shuttle Pharmaceuticals Receives FDA Approval to Proceed With Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients With Glioblastoma
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma") today announced they have received the 'Safe to Proceed' letter from the U.S....
PR NewswireJan 8 09:00 ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
GainersPortage Biotech (NASDAQ:PRTG) shares moved upwards by 20.6% to $1.7 during Wednesday's after-market session. The company's market cap stands at $33.6 million. BIMI Intl Medical (NASDAQ:BIMI) st
BenzingaJan 3 16:31 ET
No Data
No Data